This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Genuone Sciences Inc.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Hyo Jin Jeon: Innovator in Inflammatory Bowel Disease Treatment
Introduction: Hyo Jin Jeon, based in Gyeonggi-do, South Korea, is a notable inventor recognized for his contributions to the pharmaceutical field. With a keen focus on addressing significant health challenges, Jeon has developed innovative solutions aimed at improving the treatment of inflammatory bowel diseases.
Latest Patents: Jeon holds a patent for a pharmaceutical composition designed to prevent and treat inflammatory bowel disease (IBD). This inventive composition includes a mixed extract derived from at least two sources—Decne, Retzius, and Rosc—as its active ingredients. Notably, the composition demonstrates an inhibitory effect on monocyte adhesion in intestinal epithelial cells, alongside the capability to inhibit the production of inflammatory cytokines. Furthermore, it has shown promise in ameliorating colitis in animal models of dextran sodium sulfate (DSS)-induced colitis and in alleviating Crohn’s disease in animal models of 2,4,6-trinitrobenzenesulfonic acid (TNBS)-induced Crohn's disease.
Career Highlights: Hyo Jin Jeon is affiliated with Genuone Sciences Inc., where he continues to engage in groundbreaking research and development. His work directly addresses the pressing needs of those suffering from IBD, making a significant impact in the sphere of healthcare.
Collaborations: Jeon is part of a collaborative team that includes colleagues Yong-baik Cho and Seul-ki Kim. Together, they contribute to the advancements in medical science, exchanging knowledge and expertise to propel innovative solutions for complex health issues.
Conclusion: Hyo Jin Jeon stands out as an exemplary inventor with a focused mission to combat inflammatory bowel disease. His patent and collaborative efforts reflect his dedication to improving patient outcomes and advancing medical research. Through his contributions, Jeon paves the way for future innovations that may provide relief for countless individuals affected by these challenging conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile